YZYaning Zang

Yaning Zang

*This is an algorithmically generated author record based on publicly available information.

Yaning Zang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Role of Gut Microbiota in Various Neurological and Psychiatric Disorders—An Evidence Mapping Based on Quantified Evidence

    by Yaning Zang, Xigui Lai, Conghui Li, Dongfang Ding, Ying Wang, Yi Zhu

    Background and Object. There is a growing body of evidence highlighting the significant role of gut microbiota in various neurological and psychiatric disorders. We performed an evidence mapping to review the association between different microbiota and these disorders and assessed the strength of evidence for these associations. Methods. We searched PubMed, Cochrane Library, and Epistemonikos to identify systematic reviews and meta-analysis (SRs). We searched for neurological diseases and psychiatric disorders, including Alzheimers disease (AD), attention deficit hyperactivity disorder (ADHD), amyotrophic lateral sclerosis (ALS), autism spectrum disorder (ASD), anorexia nervosa (AN), bipolar disorder (BD), eating disorder (ED), generalized anxiety disorder (GAD), major depressive disorder (MDD), multiple sclerosis (MS), obsessive compulsive disorder (OCD), Parkinsons disease (PD), posttraumatic stress disorder (PTSD), spinal cord injury (SCI), schizophrenia, and stroke. We used A Measurement Tool to Assess Systematic Reviews (AMSTAR-2) to evaluate the quality of included SRs. We also created an evidence map showing the role of gut microbiota in neurological diseases and the certainty of the evidence. Results. In total, 42 studies were included in this evidence mapping. Most findings were obtained from observational studies. According to the AMSTAR-2 assessment, 21 SRs scored critically low in terms of methodological quality, 16 SR scored low, and 5 SR scored moderate. A total of 15 diseases have been investigated for the potential association between gut microbiome alpha diversity and disease, with the Shannon index and Simpson index being the most widely studied. A total of 12 diseases were investigated for potential link between beta diversity and disease. At the phylum level, Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, and Verrucomicrobia were more researched. At the genus level, Prevotella, Coprococcus, Parabacteroides, Phascolarctobacterium, Escherichia Shigella, Alistipes, Sutteralla, Veillonella, Odoribacter, Faecalibacterium, Bacteroides, Bifidobacterium, Dialister, and Blautia were more researched. Some diseases have been found to have specific flora changes, and some diseases have been found to have common intestinal microbiological changes. Conclusion. We found varied levels of evidence for the associations between gut microbiota and neurological diseases; some gut microbiota increased the risk of neurological diseases, whereas others showed evidence of benefit that gut microbiota might be promising therapeutic targets for such diseases.


  • Open Access

    Repetitive Transcranial Magnetic Stimulation for Neuropathic Pain on the Non-Motor Cortex: An Evidence Mapping of Systematic Reviews

    by Yaning Zang, Yongni Zhang, Xigui Lai, Yujie Yang, Jiabao Guo, Shanshan Gu, Yi Zhu

    Objective. This study was aimed to summarize and analyze the quality of the available evidence in systematic reviews (SRs) of repetitive transcranial magnetic stimulation (rTMS) on the non-motor cortex (non-M1) for neuropathic pain (NP) through an evidence mapping approach. Methods. We follow the Global Evidence Mapping (GEM) methodology. Searches were conducted in PubMed, EMBASE, Epistemonikos, and the Cochrane Library. The study type was restricted to SRs with or without meta-analysis. All literature published before January 23, 2021, were included. The methodological quality of the included SRs was assessed using A Measurement Tool to Assess Systematic Reviews (AMSTAR-2). Data were extracted according to a defined population-intervention-comparison-outcome (PICO) framework from primary studies that included SRs. The same PICO was categorized into PICOs according to interventions (stimulation target, frequency, number of sessions (short: 15 sessions, medium: 510 sessions, and long: >10 sessions)) and comparison (sham rTMS or other targets). The evidence mapping was presented in tables and a bubble plot. Results. A total of 23 SRs were included. According to the AMSTAR-2, 20 SRs scored very low in terms of methodological quality, 2 SRs scored low, and 1 SR scored high. A total of 17 PICOs were extracted. The dorsolateral prefrontal cortex (DLPFC) is the most studied of the non-motor cortex targets. PICOs of DLPFC, premotor cortex (PMC), frontal cortex, and secondary somatosensory cortex (S2) were mainly categorized with a potentially better conclusion. High-frequency (520Hz) rTMS of non-M1 usually lead to potentially better conclusions. Conclusions. DLPFC, PMC, frontal cortex, and S2 seem to be promising new targets for rTMS treatment of certain NP. Evidence mapping is a useful and reliable methodology to identify and present the existing evidence gap that more research efforts are necessary in order to highlight the optimal stimulation protocols for non-M1 targets and standardize parameters to fill the evidence gaps of rTMS. Further investigation is advised to improve the methodological quality and the reporting process of SRs.


  • Open Access

    Assessing Electrocardiogram and Respiratory Signal Quality of a Wearable Device (SensEcho): Semisupervised Machine Learning-Based Validation Study

    by Haoran Xu, Wei Yan, Ke Lan, Chenbin Ma, Di Wu, Anshuo Wu, Zhicheng Yang, Jiachen Wang, Yaning Zang, Muyang Yan, et al.

    Background: With the development and promotion of wearable devices and their mobile health (mHealth) apps, physiological signals have become a research hotspot. However, noise is complex in signals obtained from daily lives, making it difficult to analyze the signals automatically and resulting in a high false alarm rate. At present, screening out the high-quality segments of the signals from huge-volume data with few labels remains a problem. Signal quality assessment (SQA) is essential and is able to advance the valuable information mining of signals. Objective: The aims of this study were to design an SQA algorithm based on the unsupervised isolation forest model to classify the signal quality into 3 grades: good, acceptable, and unacceptable; validate the algorithm on labeled data sets; and apply the algorithm on real-world data to evaluate its efficacy. Methods: Data used in this study were collected by a wearable device (SensEcho) from healthy individuals and patients. The observation windows for electrocardiogram (ECG) and respiratory signals were 10 and 30 seconds, respectively. In the experimental procedure, the unlabeled training set was used to train the models. The validation and test sets were labeled according to preset criteria and used to evaluate the classification performance quantitatively. The validation set consisted of 3460 and 2086 windows of ECG and respiratory signals, respectively, whereas the test set was made up of 4686 and 3341 windows of signals, respectively. The algorithm was also compared with self-organizing maps (SOMs) and 4 classic supervised models (logistic regression, random forest, support vector machine, and extreme gradient boosting). One case validation was illustrated to show the application effect. The algorithm was then applied to 1144 cases of ECG signals collected from patients and the detected arrhythmia false alarms were calculated. Results: The quantitative results showed that the ECG SQA model achieved 94.97% and 95.58% accuracy on the validation and test sets, respectively, whereas the respiratory SQA model achieved 81.06% and 86.20% accuracy on the validation and test sets, respectively. The algorithm was superior to SOM and achieved moderate performance when compared with the supervised models. The example case showed that the algorithm was able to correctly classify the signal quality even when there were complex pathological changes in the signals. The algorithm application results indicated that some specific types of arrhythmia false alarms such as tachycardia, atrial premature beat, and ventricular premature beat could be significantly reduced with the help of the algorithm. Conclusions: This study verified the feasibility of applying the anomaly detection unsupervised model to SQA. The application scenarios include reducing the false alarm rate of the device and selecting signal segments that can be used for further research.


  • Open Access

    Assessing Electrocardiogram and Respiratory Signal Quality of a Wearable Device (SensEcho): Semisupervised Machine Learning-Based Validation Study (Preprint)

    by Haoran Xu, Wei Yan, Ke Lan, Chenbin Ma, Di Wu, Anshuo Wu, Zhicheng Yang, Jiachen Wang, Yaning Zang, Muyang Yan, et al.

    BACKGROUND With the development and promotion of wearable devices and their mobile health (mHealth) apps, physiological signals have become a research hotspot. However, noise is complex in signals obtained from daily lives, making it difficult to analyze the signals automatically and resulting in a high false alarm rate. At present, screening out the high-quality segments of the signals from huge-volume data with few labels remains a problem. Signal quality assessment (SQA) is essential and is able to advance the valuable information mining of signals. OBJECTIVE The aims of this study were to design an SQA algorithm based on the unsupervised isolation forest model to classify the signal quality into 3 grades: good, acceptable, and unacceptable; validate the algorithm on labeled data sets; and apply the algorithm on real-world data to evaluate its efficacy. METHODS Data used in this study were collected by a wearable device (SensEcho) from healthy individuals and patients. The observation windows for electrocardiogram (ECG) and respiratory signals were 10 and 30 seconds, respectively. In the experimental procedure, the unlabeled training set was used to train the models. The validation and test sets were labeled according to preset criteria and used to evaluate the classification performance quantitatively. The validation set consisted of 3460 and 2086 windows of ECG and respiratory signals, respectively, whereas the test set was made up of 4686 and 3341 windows of signals, respectively. The algorithm was also compared with self-organizing maps (SOMs) and 4 classic supervised models (logistic regression, random forest, support vector machine, and extreme gradient boosting). One case validation was illustrated to show the application effect. The algorithm was then applied to 1144 cases of ECG signals collected from patients and the detected arrhythmia false alarms were calculated. RESULTS The quantitative results showed that the ECG SQA model achieved 94.97% and 95.58% accuracy on the validation and test sets, respectively, whereas the respiratory SQA model achieved 81.06% and 86.20% accuracy on the validation and test sets, respectively. The algorithm was superior to SOM and achieved moderate performance when compared with the supervised models. The example case showed that the algorithm was able to correctly classify the signal quality even when there were complex pathological changes in the signals. The algorithm application results indicated that some specific types of arrhythmia false alarms such as tachycardia, atrial premature beat, and ventricular premature beat could be significantly reduced with the help of the algorithm. CONCLUSIONS This study verified the feasibility of applying the anomaly detection unsupervised model to SQA. The application scenarios include reducing the false alarm rate of the device and selecting signal segments that can be used for further research.